Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
AJNR. American Journal of Neuroradiology|June 13, 2020
Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging PerspectiveA Pons-Escoda, P Naval-Baudín, C Majós, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 30, 1998
U-83836E prevents kainic acid-induced neuronal damageA Camins, C Gabriel, L Aguirre, et al.
Experimental Gerontology|November 28, 2017
Resveratrol modulates response against acute inflammatory stimuli in aged mouse brainV Palomera-Ávalos, C Griñán-Ferré, V Izquierdo, et al.
Journal of Neuroscience Research|April 14, 2011
Decrease of calbindin-d28k, calretinin, and parvalbumin by taurine treatment does not induce a major susceptibility to kainic acidF Junyent, D Porquet, L de Lemos, et al.
Brain Research|December 5, 1998
Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in ratsE Escubedo, L Guitart, F X Sureda, et al.
Hippocampus|August 29, 2009
Regulation of GSK-3beta by calpain in the 3-nitropropionic acid modelN Crespo-Biel, A Camins, J Gutiérrez-Cuesta, et al.
Neuropathology and Applied Neurobiology|September 3, 2011
Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acidF Junyent, L de Lemos, E Verdaguer, et al.
British Journal of Pharmacology|February 13, 2001
Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivoD Pubill, E Verdaguer, A M Canudas, et al.
Journal of Neuroscience Research|March 4, 2000
Inhibitors of NO-synthase and donors of NO modulate kainic acid-induced damage in the rat hippocampusC Gabriel, B Friguls, F X Sureda, et al.
Pageof 9